Eco Animal Health Group PLC Notice of Results & Investor Presentation (9578E)
July 05 2023 - 2:00AM
UK Regulatory
TIDMEAH
RNS Number : 9578E
Eco Animal Health Group PLC
05 July 2023
5 July 2023
ECO Animal Health Group plc
("ECO", the "Company" or the "ECO Group")
(AIM: EAH)
Notice of Results & Investor Presentation
ECO Animal Health Group plc, a leader in the development,
registration and marketing of pharmaceutical products for global
animal health markets, will issue its results for the year ended 31
March 2023 on Monday 10 July 2023.
Investor Presentation
David Hallas, CEO, and Christopher Wilks, CFO, will be
conducting a live presentation covering the company's FY Results
for the period ended 31 March 2023. The online presentation will
take place on Wednesday 12 July at 2.30pm UK time.
This event is open to all existing and potential shareholders
and registration is free. Questions can be submitted during the
presentation and will be addressed at the end of it. Please
register using the following link:
https://www.equitydevelopment.co.uk/news-and-events/ecoanimalhealth-fyresultspresentation-12july2023
For further information please contact:
ECO Animal Health Group plc
David Hallas (CEO)
Christopher Wilks (CFO) 020 8447 8899
IFC Advisory
Graham Herring
Zach Cohen 020 3934 6630
Singer Capital Markets (Nominated Adviser
& Joint Broker)
Phil Davies
George Tzimas 020 7496 3000
Investec (Joint Broker)
Gary Clarence
Lydia Zychowska
Carlo Spingardi 020 7597 5970
Equity Development
Hannah Crowe
Matt Evans 020 7065 2692
About ECO Animal Health
ECO Animal Health Group plc researches, develops and
commercialises products for livestock. Our business strategy is to
generate shareholder value by achieving the maximum sales potential
from the existing product portfolio whilst investing in Research
and Development ("R&D") for new products, particularly
vaccines, and seeking to in-license new products.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NORUSRVROUUBRAR
(END) Dow Jones Newswires
July 05, 2023 02:00 ET (06:00 GMT)
Eco Animal Health (LSE:EAH)
Historical Stock Chart
From Oct 2024 to Nov 2024
Eco Animal Health (LSE:EAH)
Historical Stock Chart
From Nov 2023 to Nov 2024